The researchers aimed to study how duration of opioid exposure, doses used, and the risk of fracture were associated by using a self-controlled study design in an effort to minimize confounding.
The use of lasmiditan for the treatment of migraine may be associated with a dose-dependent incidence of mild to moderate dizziness.
Nearly a third of patients with migraine were found to experience vestibular-type episodic vertigo before and/or during an acute attack.
A retrospective study identified a set of clinical characteristics and triggers of vestibular migraine in the absence of a peripheral etiology for vertigo.
Vestibular rehabilitation was found to ameliorate headache, dizziness, and psychological factors in patients with vestibular migraine or a combination of tension-type headache and dizziness.
